Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model

Drug Metabolism and Disposition

Volumn 41, Issue 1, 2013, Pages 132-140

  Wei, Yuan ^a   Li, Lei ^a   Zhou, Xin ^a   Zhang, Qing Yu ^a   Dunbar, Anwar ^a   Liu, Fang ^a   Kluetzman, Kerri ^a   Yang, Weizhu ^a   Ding, Xinxin ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME; CYTOCHROME P450 2A; CYTOCHROME P450 2A13; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2S1; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMOSOME 7; CONTROLLED STUDY; CYP2A GENE; CYTOCHROME P450 2A4 GENE; CYTOCHROME P450 2A5 GENE; CYTOCHROME P450 2B10 GENE; CYTOCHROME P450 2B13 GENE; CYTOCHROME P450 2B19 GENE; CYTOCHROME P450 2B23 GENE; CYTOCHROME P450 2B9 GENE; CYTOCHROME P450 2G1 GENE; CYTOCHROME P450 2S1 GENE; EXPERIMENTAL MODEL; FEMALE; GENE; GENE CLUSTER; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENETIC RECOMBINATION; GENOMIC FRAGMENT; HYDROXYLATION; IN VIVO STUDY; MALE; MOUSE; NAL9A GENE; NALP4A GENE; NALP9C GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLEEP PATTERN; VMN1R184 GENE; VMN1R185 GENE; WILD TYPE;

ANIMALS; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION;

MUS;

EID: 84871592320     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.112.048736     Document Type: Article

References (60)

1. Bui P, Imaizumi S, Beedanagari SR, Reddy ST, and Hankinson O (2011) Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metab Dispos 39:180-190.
2. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
3. Brault V, Pereira P, Duchon A, and Hérault Y (2006) Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. PLoS Genet 2:e86.
4. Conroy JL, Fang C, Gu J, Zeitlin SO, Yang W, Yang J, VanAlstine MA, Nalwalk JW, Albrecht PJ, Mazurkiewicz JE, et al. (2010) Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat Neurosci 13:284-286.
5. Damiri B, Holle E, Yu X, and Baldwin WS (2012) Lentiviral-mediated RNAi knockdown yields a novel mouse model for studying Cyp2b function. Toxicol Sci 125:368-381.
6. Ding X and Coon MJ (1994) Steroid metabolism by rabbit olfactory-specific P450 2G1. Arch Biochem Biophys 315:454-459. (Pubitemid 24381568)
7. Ding X and Kaminsky LS (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173. (Pubitemid 37372638)
8. Ding XX and Coon MJ (1990) Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb. Mol Pharmacol 37:489-496.
9. Ferguson CS and Tyndale RF (2011) Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32:708-714.
10. Gonzalez FJ (2003) Role of gene knockout and transgenic mice in the study of xenobiotic metabolism. Drug Metab Rev 35:319-335.
11. Gu J, Cui H, Behr M, Zhang L, Zhang QY, Yang W, Hinson JA, and Ding X (2005) In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa. Mol Pharmacol 67:623-630. (Pubitemid 40365309)
12. Gu J, Dudley C, Su T, Spink DC, Zhang QY, Moss RL, and Ding X (1999) Cytochrome P450 and steroid hydroxylase activity in mouse olfactory and vomeronasal mucosa. Biochem Biophys Res Commun 266:262-267. (Pubitemid 30028802)
13. Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, and Ding X (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 278:25895-25901. (Pubitemid 36835351)
14. Gu J, Zhang QY, Genter MB, Lipinskas TW, Negishi M, Nebert DW, and Ding X (1998) Purification and characterization of heterologously expressed mouse CYP2A5 and CYP2G1: role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes. J Pharmacol Exp Ther 285:1287-1295. (Pubitemid 28277931)
15. Hérault Y, Rassoulzadegan M, Cuzin F, and Duboule D (1998) Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat Genet 20:381-384. (Pubitemid 28541639)
16. Hoffman SM, Nelson DR, and Keeney DS (2001) Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics 11:687-698. (Pubitemid 33078238)
17. Hua Z, Zhang QY, Su T, Lipinskas TW, and Ding X (1997) cDNA cloning, heterologous expression, and characterization of mouse CYP2G1, an olfactory-specific steroid hydroxylase. Arch Biochem Biophys 340:208-214. (Pubitemid 27200527)
18. Ichikawa T, Itakura T, and Negishi M (1989) Functional characterization of two cytochrome P-450s within the mouse, male-specific steroid 16 alpha-hydroxylase gene family: expression in mammalian cells and chimeric proteins. Biochemistry 28:4779-4784. (Pubitemid 19151057)
19. Johnson KA, Lerner CP, Di Lacio LC, Laird PW, Sharpe AH, and Simpson EM (1995) Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selections. Nucleic Acids Res 23:1273-1275.
20. Karlgren M, Miura S, and Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207(Suppl 2)57-61.
21. Köntgen F, Süss G, Stewart C, Steinmetz M, and Bluethmann H (1993) Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol 5:957-964. (Pubitemid 23241767)
22. Li L, Wei Y, Van Winkle L, Zhang QY, Zhou X, Hu J, Xie F, Kluetzman K, and Ding X (2011) Generation and characterization of a Cyp2f2-null mouse and studies on the role of CYP2F2 in naphthalene-induced toxicity in the lung and nasal olfactory mucosa. J Pharmacol Exp Ther 339:62-71.
23. Nagy A (2000) Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99-109.
24. Nishida CR, Lee M, and de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497-502.
25. Olson LE, Tien J, South S, and Reeves RH (2005) Long-range chromosomal engineering is more efficient in vitro than in vivo. Transgenic Res 14:325-332. (Pubitemid 40968373)
26. Raunio H, Hakkola J, and Pelkonen O (2008) The CYP2A subfamily, in Cytochrome P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics (Ioannides C, ed), pp 150-177, RSC Publishing, Cambridge, UK.
27. Ryba NJ and Tirindelli R (1997) A new multigene family of putative pheromone receptors. Neuron 19:371-379. (Pubitemid 27374235)
28. Saarikoski ST, Wikman HA, Smith G, Wolff CH, and Husgafvel-Pursiainen K (2005) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 53:549-556. (Pubitemid 40593968)
29. Scheer N, Kapelyukh Y, McEwan J, Beuger V, Stanley LA, Rode A, and Wolf CR (2012) Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines. Mol Pharmacol 81:63-72.
30. Schwenk F, Baron U, and Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080-5081. (Pubitemid 26012492)
31. Sheng J, Guo J, Hua Z, Caggana M, and Ding X (2000) Characterization of human CYP2G genes: widespread loss-of-function mutations and genetic polymorphism. Pharmacogenetics 10:667-678.
32. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343. (Pubitemid 36514866)
33. Sonderfan AJ, Arlotto MP, Dutton DR, McMillen SK, and Parkinson A (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophys 255:27-41.
34. Spitz F, Herkenne C, Morris MA, and Duboule D (2005) Inversion-induced disruption of the Hoxd cluster leads to the partition of regulatory landscapes. Nat Genet 37:889-893. (Pubitemid 41077117)
35. Su T and Ding X (2004) Regulation of the cytochrome P450 2A genes. Toxicol Appl Pharmacol 199:285-294. (Pubitemid 39208728)
36. Tian X, Pascal G, and Monget P (2009) Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol 9:202.
37. Tsuji R, Isobe N, and Kawasaki H (1996) Mechanism of prolongation of pentobarbital-induced sleeping time by empenthrin in mice. Toxicology 108:185-190. (Pubitemid 26149999)
38. van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, et al. (2007) Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J Clin Invest 117:3583-3592. (Pubitemid 350097013)
39. Wang H, Donley KM, Keeney DS, and Hoffman SM (2003) Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster. Environ Health Perspect 111:1835-1842. (Pubitemid 37526964)
40. Wang H and Tompkins LM (2008) CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab 9:598-610.
41. Wang SL, He XY, and Hong JY (2005) Human cytochrome p450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 33:336-340.
42. Wei Y, Wu H, Li L, Liu Z, Zhou X, Zhang QY, Weng Y, D'Agostino J, Ling G, Zhang X, et al. (2012) Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model. Drug Metab Dispos 40:1144-1150.
43. Wei Y, Zhou X, Fang C, Li L, Kluetzman K, Yang W, Zhang QY, and Ding X (2010) Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues. J Pharmacol Exp Ther 334:69-77.
44. Weng Y, Fang C, Turesky RJ, Behr M, Kaminsky LS, and Ding X (2007) Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Res 67:7825-7832. (Pubitemid 47281377)
45. Wu L, Gu J, Cui H, Zhang QY, Behr M, Fang C, Weng Y, Kluetzman K, Swiatek PJ, Yang W, et al. (2005) Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450. J Pharmacol Exp Ther 312:35-43. (Pubitemid 40096450)
46. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014. (Pubitemid 43894320)
47. Xiao Y, Shinkyo R, and Guengerich FP (2011) Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase. Drug Metab Dispos 39:944-946.
48. Xie F, Zhou X, Behr M, Fang C, Horii Y, Gu J, Kannan K, and Ding X (2010) Mechanisms of olfactory toxicity of the herbicide 2,6-dichlorobenzonitrile: essential roles of CYP2A5 and target-tissue metabolic activation. Toxicol Appl Pharmacol 249:101-106.
49. Xie F, Zhou X, Genter MB, Behr M, Gu J, and Ding X (2011) The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5. Drug Metab Dispos 39:947-951.
50. Yu Y and Bradley A (2001) Engineering chromosomal rearrangements in mice. Nat Rev Genet 2:780-790. (Pubitemid 33685575)
51. Zhang QY, Dunbar D, and Kaminsky LS (2003) Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab Dispos 31:1346-1351. (Pubitemid 37310323)
52. Zhang QY, Fang C, Zhang J, Dunbar D, Kaminsky L, and Ding X (2009) An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine. Drug Metab Dispos 37:651-657.
53. Zhang QY, Gu J, Su T, Cui H, Zhang X, D'Agostino J, Zhuo X, Yang W, Swiatek PJ, and Ding X (2005) Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6. Biochem Biophys Res Commun 338:318-324. (Pubitemid 41540573)
54. Zhang QY and Ding X (2008) The CYP2F, CYP2G and CYP2J subfamilies, in Cytochrome P450: Role in the Metabolism and Toxicity of Drugs and Other Xenobiotics (Ioannides C, ed), pp 309-353, RSC Publishing, Cambridge, UK.
55. Zhou X, Zhuo X, Xie F, Kluetzman K, Shu YZ, Humphreys WG, and Ding X (2010) Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model. J Pharmacol Exp Ther 332:578-587.
56. Zhou X, Wei Y, Xie F, Laukaitis CM, Karn RC, Kluetzman K, Gu J, Zhang QY, Roberts DW, and Ding X (2011) A novel defensive mechanism against acetaminophen toxicity in the mouse lateral nasal gland: role of CYP2A5-mediated regulation of testosterone homeostasis and salivary androgen-binding protein expression. Mol Pharmacol 79:710-723.
57. Zhou X, Zhang X, Weng Y, Fang C, Kaminsky L, and Ding X (2009) High abundance of testosterone and salivary androgen-binding protein in the lateral nasal gland of male mice. J Steroid Biochem Mol Biol 117:81-86.
58. Zhou X, D'Agostino J, Xie F, and Ding X (2012a) Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone in mice. J Pharmacol Exp Ther 341:233-241.
59. Zhou X, D'Agostino J, Li L, Moore CD, Yost GS, and Ding X (2012b) Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models. Drug Metab Dispos 40:642-647.
60. Zhuo X, Gu J, Behr MJ, Swiatek PJ, Cui H, Zhang QY, Xie Y, Collins DN, and Ding X (2004) Targeted disruption of the olfactory mucosa-specific Cyp2g1 gene: impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective effects on Cyp2a5 expression. J Pharmacol Exp Ther 308:719-728. (Pubitemid 38134236)